Healthcare -
Biotechnology - NASDAQ - US
$ 1.4
-1.41 %
$ 6.69 M
Market Cap
-0.14
P/E
PHIO - STOCK-BASED COMPENSATION
Stock-based Compensation PHIO - Phio Pharmaceuticals Corp.
303 K
LAST VALUE
-20.55%
2 YEAR CAGR
1.45%
5 YEAR CAGR
-17.11%
10 YEAR CAGR